Aflibercept

Red

Brand Name(s):Eylea

Indication:Neovascular (wet) age-related macular degeneration (AMD), Macular oedema following central retinal vein occlusion and Diabetic macular oedema with specific criteria, Myopic choroidal neovascularisation (myopic CNV)

Rationale:1,2

Considered:Nov-12

Review Date:Sep-21

Comments:
NICE TA409
For treating visual impairment caused by macular oedema after branch retinal vein occlusion
September 2016
…………………………
NICE TA346
Aflibercept for treating diabetic macular oedema
Aflibercept (Eylea) injections are recommended as a possible treatment for some people with sight problems caused by diabetic macular oedema,
Full guidance available at: http://www.nice.org.uk/guidance/ta346/resources/guidance-aflibercept-for-treating-diabetic-macular-oedema-pdf

July 2015
…………………………
NICE TA 305 – Info available at:
http://www.nice.org.uk/nicemedia/live/14385/66694/66694.pdf
February 2014

NICE TA 294 – Info available at:
http://www.nice.org.uk/nicemedia/live/14227/64572/64572.pdf
July 2013
…………………………